Australian vaccine set for overseas test

The effectiveness of a University of Queensland vaccine for coronavirus is about to be tested in a biosecurity facility in the Netherlands.

The vaccine will be used on live coronavirus for the first time to determine how effectively it induces protection against infection.

UQ's vaccine program co-leader Dr Keith Chappell said the trial will establish a critical package of data ahead of human clinical trials later this year. Clinical studies will be conducted by Viroclinics Xplore which offers a myriad of preclinical tests including toxicology of drugs, antibodies, and antivirals targeting viral infectious diseases.

 

UQ created COVID-19 in its laboratory and then set about designing a vaccine to combat the virus.

The vaccine locks the "spike" protein into a shape which allows the immune system to be able to recognise and neutralise it.

UQ's Professor Trent Munro said beginning a large multi-arm study at Viroclinics Xplore was critical, before human testing, because it would establish a more comprehensive understanding of how the vaccine performs.

Originally published as UQ coronavirus vaccine set for overseas test



PURSUIT: CCTV shows moment chase comes to crashing end

premium_icon PURSUIT: CCTV shows moment chase comes to crashing end

VIDEO: Neighbours heard huge bang as car crashed through brick fence

Clarence SES units face closure

premium_icon Clarence SES units face closure

Three units face an uncertain future in the region following the retirement of a...

Casino girl missing, investigations under way

Casino girl missing, investigations under way

Police are appealing for public assistance to help find teen